Andere talen Zealand Pharma A/S

Aandelen

ZEAL

DK0060257814

Beurs gesloten - Nasdaq Copenhagen Andere beurzen 16:59:46 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
586,5 ^DKK	-2,74%		-2,25%	+57,15%

23/05	Zealand Pharma kondigt topresultaten aan van de mechanistische, door onderzoekers geleide DREAM-studie met lage doses van de GLP-1/GLP-2-receptor dubbelagonist Dapiglutide	CI
16/05	Transcript : Zealand Pharma A/S, Q1 2024 Earnings Call, May 16, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

El ensayo del fármaco contra la obesidad de Zealand Pharma decepciona, pero los próximos datos son clave -- Market Talk	24/05
Zealand Pharma A/S : announces topline results from the mechanistic investigator led DREAM trial with low doses of GLP 1/GLP 2 receptor dual agonist dapiglutide	23/05
Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide	23/05
Zealand Pharma Announces Topline Results from the Mechanistic Investigator-Led Dream Trial with Low Doses of GLP-1/GLP-2 Receptor Dual Agonist Dapiglutide	23/05
Nordic Stocks Declined Thursday; Zealand Pharma Took Biggest Hit	16/05
Zealand Pharma A/S : Q1 2024 Financial Results	16/05
Zealand Pharma Announces Financial Results for the First Quarter of 2024	16/05
Zealand Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	12/05
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	12/05
Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial results	09/05
Novo Nordisk y Eli Lilly caen : AmGen avanza con un medicamento contra la obesidad	03/05
Zealand Pharma A/S : Correction to Company announcement - No. 23 / 2024	19/04
Correction to Company announcement – No. 23 / 2024	19/04
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	19/04
Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024	19/04
U.S. Futures Up, European Stocks Flat as Powell Reiterates Room for Rate Cuts This Year	04/04
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	26/03
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants	26/03
Zealand Pharma major shareholder announcement: Van Herk Investments	21/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zealand Pharma A/S

Aandelen

ZEAL

DK0060257814

Andere talen

Filters